Targovax ASA
Circio Holding ASA, a biotechnology company, develops novel circular RNA and immunotherapy medicines. The company is developing TG01, a cancer vaccine targeting driver mutations, which is in three clinical trials for multiple myeloma, and pancreatic and lung cancer; and circVec circRNA vector platform, a modular genetic cassette for biogenesis of multifunctional circRNAs in human cells. It has a … Read more
Targovax ASA (0RIS) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2021: -0.076x
Based on the latest financial reports, Targovax ASA (0RIS) has a cash flow conversion efficiency ratio of -0.076x as of June 2021.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr-24.27 Million) by net assets (Nkr320.76 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Targovax ASA - Cash Flow Conversion Efficiency Trend (2017–2020)
This chart illustrates how Targovax ASA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Targovax ASA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Targovax ASA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PT TBS Energi Utama Tbk
F:6AU
|
N/A |
|
Enzo Biochem Inc
NYSE:ENZ
|
-0.074x |
|
D3 Energy Ltd
AU:D3E
|
-0.326x |
|
Pacific Online Limited
PINK:PCOLF
|
-0.008x |
|
MMP Industries Limited
NSE:MMP
|
0.079x |
|
Yjn Co.,Ltd.
TWO:3191
|
-0.212x |
|
OY Nofar Energy Ltd
TA:NOFR
|
-0.011x |
|
Concord Medical Services Holdings
NYSE:CCM
|
0.009x |
Annual Cash Flow Conversion Efficiency for Targovax ASA (2017–2020)
The table below shows the annual cash flow conversion efficiency of Targovax ASA from 2017 to 2020.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2020-12-31 | Nkr372.59 Million | Nkr-110.79 Million | -0.297x | +38.04% |
| 2019-12-31 | Nkr296.95 Million | Nkr-142.52 Million | -0.480x | -61.18% |
| 2018-12-31 | Nkr374.70 Million | Nkr-111.57 Million | -0.298x | -40.51% |
| 2017-12-31 | Nkr507.16 Million | Nkr-107.47 Million | -0.212x | -- |